The effects of exosite occupancy on the substrate specificity of thrombin
- PMID: 19638274
- DOI: 10.1016/j.abb.2009.07.012
The effects of exosite occupancy on the substrate specificity of thrombin
Abstract
Thrombin (EC 3.4.4.13) has two exosites that mediate interactions between the enzyme and its substrates and cofactors. The binding of ligands to the exosites alters the functions of the protease, for example, when the cofactor thrombomodulin binds to both exosites I and II, it converts the enzyme from a procoagulant to an anticoagulant factor. It is unknown whether ligand binding to a thrombin exosite will alter the substrate specificity of the enzyme and thus contribute to the changed substrate repertoire of the enzyme upon engagement with cofactors. We first examined whether binding of ligands to exosites I and II altered the activity of the enzyme against fluorogenic peptide substrates. The efficiency of cleavage of substrates by thrombin did change when thrombomodulin or hirugen was present, indicating that exosite I occupancy changed the active site of the protease. The presence of heparin did not change the activity of the enzyme, indicating that exosite II occupancy had little effect on active site function. Investigation of the effects of exosite I occupancy by hirugen on thrombin specificity using phage display substrate libraries revealed that the ligand only changed the specificity of the enzyme to a small degree. Occupancy of both exosites by thrombomodulin induced greater changes to the specificity of the enzyme, with the prime side showing broader changes in amino acid frequencies. Thus, exosite I ligands do affect the activity and specificity of thrombin, but not greatly enough to explain the altered substrate profile of the enzyme when complexed with thrombomodulin.
Similar articles
-
Allosteric changes of thrombin catalytic site induced by interaction of bothrojaracin with anion-binding exosites I and II.Biochem Biophys Res Commun. 1999 Sep 7;262(3):819-22. doi: 10.1006/bbrc.1999.1297. Biochem Biophys Res Commun. 1999. PMID: 10471408
-
Energetics of thrombin-thrombomodulin interaction.Biochemistry. 1997 Jun 3;36(22):6674-81. doi: 10.1021/bi962766a. Biochemistry. 1997. PMID: 9184147
-
Thrombin specificity.Thromb Haemost. 1995 Jul;74(1):129-33. Thromb Haemost. 1995. PMID: 8578445 Review.
-
Autoantibodies to thrombin directed against both of its cryptic exosites.Br J Haematol. 2006 Feb;132(4):487-93. doi: 10.1111/j.1365-2141.2005.05894.x. Br J Haematol. 2006. PMID: 16412021
-
[Inducing conformational changes in thrombin by ligands as a way of regulating its activity].Biokhimiia. 1996 Jul;61(7):1139-51. Biokhimiia. 1996. PMID: 9035728 Review. Russian.
Cited by
-
Role of electrostatic interactions in binding of thrombin to the fibrinogen γ' chain.Biochemistry. 2012 Apr 24;51(16):3445-50. doi: 10.1021/bi2016519. Epub 2012 Apr 15. Biochemistry. 2012. PMID: 22439748 Free PMC article.
-
Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite Function.PLoS One. 2016 Jun 15;11(6):e0157471. doi: 10.1371/journal.pone.0157471. eCollection 2016. PLoS One. 2016. PMID: 27305147 Free PMC article.
-
Ligand binding to anion-binding exosites regulates conformational properties of thrombin.J Biol Chem. 2013 Mar 22;288(12):8667-8678. doi: 10.1074/jbc.M112.410829. Epub 2013 Feb 1. J Biol Chem. 2013. PMID: 23378535 Free PMC article.
-
The extended cleavage specificity of human thrombin.PLoS One. 2012;7(2):e31756. doi: 10.1371/journal.pone.0031756. Epub 2012 Feb 27. PLoS One. 2012. PMID: 22384068 Free PMC article.
-
Designing allosteric regulators of thrombin. Monosulfated benzofuran dimers selectively interact with Arg173 of exosite 2 to induce inhibition.J Med Chem. 2012 Aug 9;55(15):6888-97. doi: 10.1021/jm300670q. Epub 2012 Jul 25. J Med Chem. 2012. PMID: 22788964 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical